$SPCX

SpaceX lockup expires today, with stock bucking higher

SpaceX (SPCX) faces its first and largest stock lockup expiration on Thursday, when 911.5 million shares become eligible to trade, raising freely tradable shares to 11.8% from 4.9%. The eligible tranche was valued at about $98.7 billion at the Aug. 5 close of $108.27. Analysts at Morningstar, JPMorgan, Mizuho, and Bank of America expect selling pressure may be partly priced in or pre-positioned.

Original reporting
Published Aug 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 4:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX lockup expires today, with stock bucking higher — source image
Decision brief

The 30-second read

$SPCXNeutralMed
01

Why it matters

The first and largest tranche becomes eligible today, potentially increasing freely tradable shares from 4.9% to 11.8% and creating a near-term technical drag, especially given the stock is already below IPO price after a post-earnings sell-off.

02

Market read

Traders can use today’s unlock as a catalyst for intraday positioning and volatility management, while monitoring whether selling actually materializes versus being pre-positioned.

03

What to watch

Eligibility does not guarantee immediate sales; actual float turnover, hedging flows, and whether buyers step in after the stock is already below IPO price can dominate the unlock effect.

Relevance 7/10Novelty 6/10Timing: today’s first lockup unlock (Aug 6)

Background

SpaceX’s IPO included insider and pre-IPO lockups, with expirations staggered across nine tranches rather than a single unlock date.

Company-level read

Ticker impact

$SPCXNeutralMedium confidence
Context

SpaceX’s first lockup tranche expires today, making 911.5M shares eligible and expanding freely tradable float sharply.

Expected impact

Expect elevated volatility around today’s unlock, with downside risk if selling materializes; stabilization possible if selling is already priced or staged.

Evidence & confidence

The article cites a large first tranche (911.5M shares) and notes mixed Street views: some expect most shares to sell, others argue pre-positioning and eligibility does not equal immediate market supply.

Market effects

Could influence sentiment toward other high-growth IPOs with staggered lockups, but impact is company-specific.

Limited spillover expected beyond US growth/IPO sentiment.

Low global relevance; primarily a US-listed single-name technical event.

Counterpoint

If most holders already pre-sold, today’s eligibility may not translate into incremental selling, turning the unlock into a volatility event rather than a sustained downtrend.

Key entities

  • SpaceX

    Subject of the article; its first lockup tranche expires today, increasing eligible shares and public float.

  • Morningstar (Nicolas Owens)

    Expects most available shares to come to market, though some damage may already be priced.

  • JPMorgan (Doug Anmuth)

    Notes pre-positioning and that eligibility does not mean the full tranche will be offered immediately.

  • Bank of America (Ron Epstein)

    Frames the unlock as a near-term technical pressure rather than a fundamental verdict.

  • Morgan Stanley (Adam Jonas)

    Frames the expiration as a buying opportunity based on long-term compounding narrative.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.